Mirum Pharmaceuticals, Inc. (MIRM)
96.42
-0.48
(-0.50%)
USD |
NASDAQ |
Apr 15, 16:00
96.42
0.00 (0.00%)
After-Hours: 16:49
Mirum Pharmaceuticals Research and Development Expense (Annual) : 185.83M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| BridgeBio Pharma, Inc. | 451.95M |
| BioMarin Pharmaceutical, Inc. | 700.97M |
| Insmed, Inc. | 771.09M |
| Ionis Pharmaceuticals, Inc. | 913.18M |
| Cogent Biosciences, Inc. | 265.16M |